Literature DB >> 27743737

Total parietal peritonectomy with en bloc pelvic resection for advanced ovarian cancer with peritoneal carcinomatosis.

Hee Seung Kim1, Robert E Bristow2, Suk-Joon Chang3.   

Abstract

OBJECTIVE: The majority of advanced ovarian cancer patients have peritoneal carcinomatosis involving from the pelvis to upper abdomen, which is a major obstacle to optimal cytoreduction. Since total parietal peritonectomy was introduced for treating peritoneal carcinomatosis from colorectal cancer [3], similar surgical techniques including pelvic peritonectomy have been applied in advanced ovarian cancer with peritoneal carcinomatosis [1], and these can increase the rate of complete cytoreduction up to 60% [2]. However, there are few reports on total parietal peritonectomy for ovarian cancer patients. In this surgical film, we showed total parietal peritonectomy with en bloc pelvic resection for treating advanced ovarian cancer with peritoneal carcinomatosis.
METHODS: A 43years-old woman was diagnosed with high-grade serous carcinoma of the ovary after right adnexectomy. Computed tomography demonstrated subdiaphragmatic involvements, omental cake, lymph node metastases and huge pelvic mass infiltrating the uterus, cul-de-sac, and pelvic peritoneum. Primary debulking surgery was considered because of a high likelihood for complete cytoreduction.
RESULTS: First, the whole abdomen and pelvis were adequately exposed and the visceral organs thoroughly mobilized. Then, the parietal peritoneum was dissected from the subdiaphragmatic, paracolic and pelvic areas. Tumor-infiltrated visceral organs such as the uterus, adnexae, rectosigmoid colon and cul-de-sac were resected en bloc with the parietal peritoneum (Fig. 1).
CONCLUSIONS: Total parietal peritonecotmy with en bloc pelvic resection is a feasible procedure for removing peritoneal metastasis in advanced ovarian cancer patients, which contributes to optimal cytoreduction improving prognosis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Advanced ovarian cancer; Cytoreductive surgery; En bloc pelvic resection; Total parietal peritonectomy

Mesh:

Year:  2016        PMID: 27743737     DOI: 10.1016/j.ygyno.2016.10.014

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Clinical Phenotypes of Tumors Invading the Rectosigmoid Colon Affecting the Extent of Debulking Surgery and Survival in Advanced Ovarian Cancer.

Authors:  Soo Jin Park; Jaehee Mun; Eun Ji Lee; Sunwoo Park; Sang Youn Kim; Whasun Lim; Gwonhwa Song; Jae-Weon Kim; Seungmee Lee; Hee Seung Kim
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

2.  Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC-IV ovarian cancer.

Authors:  Roberto Tozzi; Jvan Casarin; Ahmet Baysal; Gaetano Valenti; Yakup Kilic; Hooman Soleymani Majd; Matteo Morotti
Journal:  J Gynecol Oncol       Date:  2018-11-30       Impact factor: 4.401

3.  Impact of extent of parietal peritonectomy on oncological outcome after cytoreductive surgery and HIPEC.

Authors:  S P Somashekhar; K R Ashwin; Ramya Yethadka; Shabber S Zaveri; Vijay K Ahuja; Amit Rauthan; Kumar C Rohit
Journal:  Pleura Peritoneum       Date:  2019-11-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.